Opportunity for Iopofosine Expansion Within Areas of High Unmet Need in Non-Hodgkin’s Lymphoma Establishes...
Management to host a conference call today at 8:30 am ET WM pivotal study data to be announced in June...
FLORHAM PARK, N.J., May 08, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.